Cullen/Frost Bankers’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-21
Closed -$463 1479
2024
Q4
$463 Buy
+21
New +$463 ﹤0.01% 1294
2023
Q2
Sell
-203
Closed -$1.8K 1270
2023
Q1
$1.8K Sell
203
-262
-56% -$2.32K ﹤0.01% 1108
2022
Q4
$4.24K Hold
465
﹤0.01% 983
2022
Q3
$4K Buy
465
+203
+77% +$1.75K ﹤0.01% 1026
2022
Q2
$2K Hold
262
﹤0.01% 1010
2022
Q1
$2K Hold
262
﹤0.01% 1060
2021
Q4
$2K Hold
262
﹤0.01% 1085
2021
Q3
$3K Hold
262
﹤0.01% 1154
2021
Q2
$3K Hold
262
﹤0.01% 1149
2021
Q1
$3K Sell
262
-109
-29% -$1.25K ﹤0.01% 1013
2020
Q4
$4K Hold
371
﹤0.01% 970
2020
Q3
$3K Hold
371
﹤0.01% 1000
2020
Q2
$5K Sell
371
-8,618
-96% -$116K ﹤0.01% 967
2020
Q1
$81K Buy
8,989
+8,618
+2,323% +$77.7K ﹤0.01% 467
2019
Q4
$4K Sell
371
-900
-71% -$9.7K ﹤0.01% 970
2019
Q3
$9K Hold
1,271
﹤0.01% 844
2019
Q2
$12K Sell
1,271
-1,279
-50% -$12.1K ﹤0.01% 808
2019
Q1
$40K Buy
+2,550
New +$40K ﹤0.01% 595
2017
Q4
Sell
-11,331
Closed -$199K 396
2017
Q3
$199K Sell
11,331
-725
-6% -$12.7K 0.01% 375
2017
Q2
$401K Buy
12,056
+555
+5% +$18.5K 0.01% 296
2017
Q1
$369K Buy
11,501
+344
+3% +$11K 0.01% 305
2016
Q4
$405K Buy
11,157
+1,737
+18% +$63.1K 0.01% 296
2016
Q3
$433K Sell
9,420
-1,418
-13% -$65.2K 0.02% 279
2016
Q2
$545K Buy
10,838
+630
+6% +$31.7K 0.02% 269
2016
Q1
$546K Sell
10,208
-122
-1% -$6.53K 0.02% 269
2015
Q4
$678K Sell
10,330
-352
-3% -$23.1K 0.03% 257
2015
Q3
$603K Buy
10,682
+36
+0.3% +$2.03K 0.02% 265
2015
Q2
$629K Sell
10,646
-2,069
-16% -$122K 0.02% 279
2015
Q1
$793K Sell
12,715
-15,664
-55% -$977K 0.03% 263
2014
Q4
$1.63M Sell
28,379
-22,605
-44% -$1.3M 0.06% 210
2014
Q3
$2.74M Sell
50,984
-9,350
-15% -$502K 0.11% 166
2014
Q2
$3.16M Sell
60,334
-6,871
-10% -$360K 0.13% 164
2014
Q1
$3.55M Buy
67,205
+7,417
+12% +$392K 0.15% 154
2013
Q4
$2.4M Sell
59,788
-5,065
-8% -$203K 0.11% 175
2013
Q3
$2.45M Sell
64,853
-12,901
-17% -$487K 0.12% 168
2013
Q2
$3.05M Buy
+77,754
New +$3.05M 0.16% 160